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Background: Hypertensive disorders of pregnancy are important causes of morbidity and mortality. The levels of calcium
(Ca2+) and magnesium (Mg2+) in pregnancy may implicate their possible role in pregnancy-induced hypertension. This
study assessed serum Ca2+ and Mg2+ levels in women with PIH (pregnancy-induced hypertension) and PE (pre-eclampsia),
compared to that in normal pregnancy.
Methods: This case–control study was conducted on 380 pregnant women (≥20 weeks gestation) receiving antenatal
care at three hospitals in the Cape Coast metropolis, Ghana. This comprised 120 women with PIH, 100 women with PE
and 160 healthy, age-matched pregnant women (controls). Demographic, anthropometric, clinical and obstetric data were
gathered using an interview-based questionnaire. Venous blood samples were drawn for the estimation of calcium and
magnesium.
Results: Systolic blood pressure (SBP) and diastolic blood pressure (DBP) were significantly raised in women with
PIH (p < 0.0001) and PE (p < 0.0001). Women with hypertensive disorders (PE and PIH) had significantly lower
serum calcium and magnesium levels than those in the control group (p < 0.0001 each). Of those with PIH, SBP
correlated positively with BMI (r = 0.575, p < 0.01) and Ca2+ correlated positively with Mg2+ (r = 0.494, p < 0.01). This was
similar amongst the PE group for SBP and BMI as well as for Ca2+and Mg2+ but was not significant. Multivariate analysis
showed that women aged ≥40 years were at a significant risk of developing PIH (OR = 2.14, p = 0.000).
Conclusion: In this study population, serum calcium and magnesium levels are lower in PIH and PE than in normal
pregnancy. Mineral supplementation during the antenatal period may influence significantly, the occurrence of
hypertensive disorders in pregnancy.
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Hypertensive disorders of pregnancy, such as pre-
eclampsia (PE) and pregnancy-induced hypertension
(PIH) are a major cause of maternal morbidity [1]. The
incidence rate of pre-eclampsia stands at 3–10% glo-
bally, [2] with a 7% rate reported amongst Ghanaian* Correspondence: osakunor@gmail.com
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unless otherwise stated.pregnant women [3,4]. Taking into account numerous
studies conducted, the aetiology of this condition re-
mains unknown [5], although factors such as obesity,
diabetes, calcium (Ca2+) deficiency [6], advanced ma-
ternal age, oxidative stress, placental ischemia, genetics
and immune maladaptation have been implicated [7].
PIH develops due to pregnancy and regresses after
delivery. It is a known cause of premature delivery, intra-
uterine growth restriction (IUGR), placental abruption,
foetal death, and numerous adverse pregnancy outcomes.
Previous history of pre-eclampsia, pre-existing diabetes,l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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age (≥40 years) have been reported to increase the risk of
PIH and thus PE [7-9].
Previous reports have considered the association be-
tween hypertensive disorders of pregnancy (PE and PIH)
and serum electrolytes, particularly Ca2+ and magnesium
(Mg2+) [10-13]. It has been reported that there are re-
duced levels of Ca2+ and Mg2+ in pre-eclampsia [12,13].
Meanwhile, a recent report from Nigeria has indicated
that apart from raised levels of sodium in pre-eclampsia,
Ca2+ and Mg2+ were within normal reference intervals
[14]. To date, a study on Ca2+ and Mg2+ levels amongst
women presenting with PE and PIH is non-existent in
Ghana, although the use of magnesium sulphate remains
the treatment of choice, especially in eclampsia. Are
there changes in levels of these electrolytes and are these
changes a contributing factor to the causation of hyper-
tensive disorders of pregnancy in Ghana? It is therefore
expedient to address this gap, with the aim of providing
preliminary data that could influence the prevention and
management of PE and PIH in Ghana.
We assessed the levels of serum Ca2+ and Mg2+ in
women presenting with PE and PIH, compared to that
in normal pregnancy. We further assessed factors that




This multicenter case–control study with consecutive
sampling was conducted in the Cape Coast metropolis,
Ghana, from December 2013 to May, 2014. The hospitals
involved in the study included, the Cape Coast Teaching
Hospital (CCTH), University of Cape Coast Hospital
(UCCH) and the Cape Coast metropolitan hospital.
Cape Coast covers a total land mass of 9,826 square
kilometres (2223.9843 acres) with an estimated popula-
tion of 1,805,488 [15].
Ethical consent
The study was approved by the Institutional Review Board
of the University of Cape Coast (IRB-UCC) and author-
ities of the selected hospitals. Participation was voluntary
and written informed consent was obtained from each
participant.
Eligibility criteria
Pregnant women with gestational age 20 weeks or more
were eligible participants for this study. Participants in
good health, normotensive and without dipstick (re-
agent strip) proteinuria were enrolled as controls. Par-
ticipants with elevated blood pressure (≥140/90 mmHg)
with or without dipstick proteinuria (≥“+”) were en-
rolled as cases (PE and PIH respectively). Pregnantwomen with chronic hypertension, on antihypertensive
therapy, eclampsia, diabetes, autoimmune disease and
renal disease were excluded from the study.
Study population
Three hundred and eighty (380) participants (≥20 weeks
gestation) were involved in the study. This included
160 age-matched, pregnant normotensive women, 120
pregnant women with PIH and 100 pregnant women
with PE, receiving antenatal care at the selected centres.
Participants with high blood pressure (≥140/90 mmHg)
on two occasions, at least four hours apart, with visible
dipstick proteinuria (≥“+”), were categorised as PE and
those without proteinuria were categorised as PIH [1,16].
A standard interview-based questionnaire was used to ob-
tain data on demography, clinical and family history.
Anthropometric measurements
Height (to the nearest 0.1 cm) without shoes was mea-
sured with a wall-mounted ruler. Weight (to the nearest
0.1 kg) in light clothing was measured with a bathroom
scale (Zhongshan Camry Electronic Co. Ltd, Guangdong,
China). BMI was calculated using the formula; weight
(kg)/height (m2).
Blood pressure measurement
Trained personnel measured the blood pressure of par-
ticipants in accordance with recommendations of the
American Heart Association [17]. Repeated measurements
were taken within 5–10 minutes rest interval and the
mean value was recorded as the blood pressure.
Urinalysis
Participants provided 10–20 ml of freshly voided early
morning urine in clean, wide-mouthed, leak-proof con-
tainers. Urinalysis was performed using a dipstick,
semi-qualitative method as per manufacturer’s instruc-
tions (CYBOW™ DFI Co Ltd, Gimhae-City, Republic of
Korea). Proteinuria in participants with pre-eclampsia
was defined as the presence of urinary protein in con-
centrations ≥ “+”, using the semi-quantitative colour
scale on the urine reagent dipstick [16].
Blood sample collection and biochemical analysis
After observing an overnight fast, 4 ml of venous blood
sample was taken from each participant into serum sep-
arator tubes (Becton Dickinson, Rutherford, NJ).
Blood samples were allowed to clot and centrifuged at
3000 rpm for 3–5 minutes within 30 minutes of sample
collection. Serum Ca2+ and Mg2+ was estimated immedi-
ately, using an automated electrolyte analyser (FT-1000
Automatic Chemical analyser, Fortune company Limited,
Chengdu, China).
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Data was entered and stored in Microsoft Excel and ana-
lysed using SPSS version 16.0 (SPSS Inc. Chicago). Cat-
egorical variables were analysed using Chi-square and
Fischer’s tests whilst continuous variables were analysed
using the unpaired t-test. Multiple groups were com-
pared using One-way ANOVA coupled with Dunnett
multiple comparisons. Pearson’s correlation and multiple
logistic regression analyses were performed to determine
the relationship between variables and to identify inde-
pendent factors associated with hypertensive disorders
(PIH and PE) respectively. In all statistical tests, a value
of p <0.05 was considered significant.
Results
As shown in Table 1, there was no significant differ-
ence in maternal and gestational ages between the
three groups compared. Mean blood pressure (SBP and
DBP) was significantly higher in women with PIH
(SBP = 155, DBP = 101; p < 0.0001) and PE (SBP = 152
DBP = 102; p < 0.0001), compared to those in the con-
trol group (SBP = 112, DBP = 65).
In Figure 1, there was a significantly lower mean
serum Ca2+ and Mg2+ levels amongst pregnant womenTable 1 Demographic, clinical and obstetric related character
Variables Control αp-value
(n = 160)
Age (years) 30.70 ± 4.24 0.0809
SBP (mmHg) 112.50 ± 8.40 < 0.0001
DBP (mmHg) 65.25 ± 6.40 < 0.0001
BMI (kgm−2) 28.25 ± 5.67 0.4827
Gestational age (weeks) 31.92 ± 4.69 0.6320
Gravidity n (%)
Primigravida 80 (50.0) 0.9626
Secundigravida 36 (22.5) 0.2865
Multigravida 44 (27.5) 0.1133
Parity n (%)
Nulliparous 88 (55.0) 0.9904
Primiparous 40 (25.0) 0.9451
Multiparous 32 (20.0) 0.4346
Contraceptive use n (%)
Yes 68 (42.5) 0.3922
History of Abortion n (%)
Yes 40 (25.0) 0.2793
New paternity n (%)
Yes 40 (25.0) 0.7022
Values are in mean ± SD and frequency (proportion) where appropriate. Comparison
coupled with Dunnett multiple comparisons was used to compare multiple groups.
PIH & PE); γp-value (comparison between controls & PE). PIH: Pregnancy-induced hy
blood pressure. Data in boldface indicate statistical significance.with hypertensive disorders (PE and PIH) than in the
corresponding control group (p < 0.0001). There was no
significant difference in the mean serum Ca2+ (p = 0.538)
and Mg2+ (p = 0.211) levels between women with PIH
and PE although lower in women with PE.
All women with PIH and PE had hypocalcaemia (100%
each). The proportion of women with PIH and PE with
hypomagnesaemia was 86.7% and 100% respectively. Of
the 160 pregnant women in the control group, 8 (5%)
had hypocalcaemia and 24 (15%) had hypomagnesaemia.
One hundred and fifty-two (152) pregnant women,
representing 40%, of the total population were over-
weight. Of this, 64 (40%) were from the control group,
36 (30%) were women with PIH and 52 (52%) were
women with PE [Table 2].
There was a significant positive correlation between
the DBP and SBP (r = 0.370, p < 0.05), BMI and SBP
(r = 0.434, p < 0.01) and between Ca2+and Mg2+ (r = 0.841,
p < 0.01) amongst the control group (Tables 3 and 4).
Of those with PIH, SBP correlated positively with BMI
(r = 0.575, p < 0.01), with a similar observation between
serum Ca2+and Mg2+ levels (r = 0.494, p < 0.01) (Table 3).
A similar trend of positive association between SBP and
BMI as well as between Ca2+and Mg2+ was observedistics of the study population
PIH βp-value PE γp-value
(n = 120) (n = 100)
30.03 ± 6.74 0.2817 32.28 ± 8.58 0.0560
155.17 ± 10.21 0.2935 152.60 ± 7.09 < 0.0001
101.63 ± 7.84 0.5133 102.24 ± 6.81 < 0.0001
29.70 ± 11.43 0.9381 29.04 ± 7.61 0.4484
31.40 ± 4.27 0.4993 30.72 ± 2.84 0.2518
56 (46.7) 0.8949 56 (56.0) 0.7885
48 (40.0) 0.0675 12 (12.0) 0.5693
16 (13.3) 0.2484 32 (32.0) 0.9364
68 (56.7) 0.9693 60 (60.0) 0.9246
36 (30.0) 0.4769 16 (16.0) 0.6286
16 (13.3) 0.5936 24 (24.0) 0.9748
32 (26.7) 0.9103 32 (32.0) 0.6989
12 (10.0) 0.9723 12 (12.0) 0.4437
20 (16.7) 0.2610 36 (36.0) 0.6377
between proportions was done using Fischer’s exact test. One-way ANOVA
α P-value (comparison between control & PIH); βp-value (comparison between
pertension; PE: Pre-eclampsia, SBP: Systolic blood pressure; DBP: Diastolic
Figure 1 Mean Ca2+ and Mg2+ levels in PIH, PE and the control group. PIH: Pregnancy-induced Hypertension, PE: Pre-eclampsia, Ca2+: Calcium,
Mg2+: Magnesium. P < 0.05 was considered significant for statistical comparisons using the t-test.
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[Table 4].
The effect of different variables on the risk of develop-
ing PIH and PE is shown in Table 5. The only significant
factor in this study that increased pregnant women’s risk
of PIH, as determined by multivariate analysis was age.
Pregnant women aged 40 years and above were about
two times more likely to develop PIH than women
under 25 years of age (OR = 2.14, p = 0.000).
Discussion
Hypertensive disorders of pregnancy are associated
with increased morbidity and mortality, especially dur-
ing delivery [1]. Our study was conducted to assess the
levels of serum Ca2+ and Mg2+ in pregnant women with
PE and PIH compared to that in normal pregnancy. It
also identified factors that may contribute to an in-
creased risk of PIH and PE. To date, no such study has
been conducted in Ghana. Our results showed that levels
of serum Ca2+ and Mg2+ was significantly reduced in
women with PE and PIH and advanced maternal ageTable 2 Prevalence of overweight, obesity, hypocalcaemia an
Variables Controls (n = 160) PIH (n
BMI (kg/m2)
BMI >25 64 (40.0%) 36 (30.
BMI <25 96 (60.0%) 84 (70.
Obese (≥30) 52 (32.5%) 44 (36.
Non-obese (<30) 108 (67.5%) 76 (63.
Ca2+ (mmol/l)
Low (<2.1) 8 (5.0%) 120 (10
Normal (2.1-2.8) 152 (95.0%) 0 (0.0%
Mg2+ (mmol/l)
Low (<1.5) 24 (15.0%) 104 (86
Normal (1.5-2.0) 136 (85.0%) 16 (13.
BMI = Body Mass Index, Ca2+ = Calcium, Mg2+ = Magnesium, PIH: Pregnancy-induced(≥40) was associated with a higher risk of developing PIH.
The present study adds to implications on the aetiology of
hypertension in pregnancy in Ghana and may influence
prevention and treatment through mineral supplementa-
tion during the antenatal period.
Hypertensive disorders are the commonest medical
complications that develop during pregnancy, character-
ized by an increase in blood pressure. In accordance
with presentation of the condition, the present study
showed that systolic and diastolic blood pressure was
significantly raised in women with PIH and PE [9,18].
Serum calcium and magnesium are very important
for metabolism at the cellular level and are vital for
muscle contraction, cell death and neuronal activity
[13], making it very essential in pregnancy. The obser-
vation of low Ca2+ and Mg2+ levels is in agreement with
other studies on hypertensive disorders in pregnancy
[10,12,13,19]. A probable theory to this observation may
be that when serum calcium levels decreased, the levels of
intracellular calcium increased, leading to constriction of
smooth muscles in blood vessels and therefore increasedd hypomagnesaemia amongst study participants
= 120) PE (n = 100) Total (Prevalence)
0%) 52 (52.0%) 152 (40.0%)
0%) 48 (48.0%) 228 (60.0%)
7%) 24 (24.0%) 120 (31.6%)
3%) 76 (76.0%) 260 (68.4%)
0.0%) 100 (100.0%) 228 (60.0%)
) 0 (0.0%) 152 (40.0%)
.7%) 100 (100.0%) 228 (60.0%)
3%) 0 (0.0%) 152 (40.0%)
hypertension; PE: Pre-eclampsia.
Table 3 Pearson’s correlation co-efficient of association
between variables for the control (lower left-hand side)
and PIH (upper right-hand side) groups
Variable Age SBP DBP GA BMI Ca2+ Mg2+
Age 0.047 0.100 −0.215 0.020 −0.181 0.059
SBP 0.194 0.115 0.149 0.575** −0.314 −0.083
DBP 0.201 0.370* −0.321 0.129 −0.221 0.158
GA −0.085 −0.015 −0.166 0.329 0.038 −0.234
BMI 0.303 0.434** 0.068 0.011 0.045 0.151
Ca2+ 0.179 −0.181 −0.130 0.023 0.020 0.494**
Mg2+ 0.147 −0.201 −0.111 −0.043 −0.113 0.841**
*Correlation is significant at the 0.05 level (2-tailed). **Correlation is significant
at the 0.01 level (2-tailed). GA: Gestational Age; BMI: Body Mass Index: DBP:
Diastolic Blood Pressure; SBP: Systolic Blood Pressure. Data in boldface indicate
statistical significance.
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and diastolic blood pressure. Furthermore, previous re-
ports suggest that altered calcium homoeostasis, as exhib-
ited by increased calcium excretion, is associated with
higher blood pressure levels [23]. Low serum calcium
levels may also increase blood pressure by stimulating
parathyroid hormone and rennin release, which in turn in-
creases intracellular calcium in smooth muscle, leading to
vasoconstriction [24]. The observation is further sup-
ported by the 2011 WHO recommendation, which found
a higher risk of pre-eclampsia in pregnant women with
low dietary intake of calcium and recommended supple-
mentation for such women [25]. This implies that calcium
levels may play a role in hypertensive disorders in
pregnancy.
Golmohammad Lou et al. [26] have disputed the role
of calcium and trace elements in high blood pressure,
for that matter, in pre-eclampsia. They explained that,
although slightly lower, there was no significant differ-
ence in calcium and magnesium levels between women
with pre-eclampsia and normal, healthy pregnant
women [26]. This however, is slightly contentious asTable 4 Pearson’s correlation co-efficient of association
between variables for the control (lower left-hand side)
and PE (upper right-hand side) groups
Variable Age SBP DBP GA BMI Ca2+ Mg2+
Age 0.197 0.267 0.346 −0.239 0.054 −0.118
SBP 0.194 0.254 −0.066 0.095 0.011 0.284
DBP 0.201 0.370* 0.012 −0.209 0.078 0.236
GA −0.085 −0.015 −0.166 0.309 −0.139 −0.190
BMI 0.303 0.434** 0.068 0.011 −0.387 −0.356
Ca2+ 0.179 −0.181 −0.130 0.023 0.020 0.106
Mg2+ 0.147 −0.201 −0.111 −0.043 −0.113 0.841**
*Correlation is significant at the 0.05 level (2-tailed). **Correlation is significant
at the 0.01 level (2-tailed). GA: Gestational Age; BMI: Body Mass Index: DBP:
Diastolic Blood Pressure; SBP: Systolic Blood Pressure. Data in boldface indicate
statistical significance.magnesium supplementation during treatment of pre-
eclampsia and seizures, has been shown to oppose
calcium-dependent arterial constriction and may
antagonize the increase in intracellular calcium con-
centration. A Cochrane review as well as recommen-
dations by the WHO on prevention and management
of pre-eclampsia and eclampsia have consistently sup-
ported that supplementation of these minerals in preg-
nancy is associated with a significant reduction in the
risk of pre-eclampsia [25,27,28]. Therefore, exemp-
tions to the fact that low calcium and magnesium
levels exist in such conditions may not be justified.
The observed low levels of magnesium in women
with PIH and PE could be due to decreased dietary in-
take, increased clearance by the kidneys, haemodilution
due to expansion of the extracellular space and in-
creased consumption of minerals by the growing foetus
[13]. This together with lowered calcium levels play a
role in the development of hypertensive disorders in
pregnancy. Other researchers have proposed that a re-
duction in the level of extracellular Mg2+ causes partial
membrane depolarization and decreased repolarisation
along with opening of Ca2+ membrane channels, lead-
ing to an intracellular Ca2+ shift. Furthermore, the
existing increase in the foetal Ca2+ demand may also
block bone resorption of Ca2+ with a concurrent intra-
cellular pull [19,29]. This phenomenon produces vaso-
constriction together with an increase in the blood
pressure, as seen in PIH and PE.
The effect of Mg2+ and Ca2+ in the pathogenesis of
hypertensive disorders in pregnancy is supported by the
observed positive correlation between magnesium and
calcium in all participating groups, although not signifi-
cant amongst those with PE.
Further correlation analysis showed a positive associ-
ation between BMI and SBP in all groups and was sig-
nificant amongst both controls and those with PIH but
not PE. This relationship is similar to findings from
other studies [30-33]. The observed association is thought
to be as a result of the role of obesity-mediated inflamma-
tion in the pathogenesis of PIH [34].
Multivariate logistic regression showed that preg-
nancy in advanced maternal age (≥40 years) was associ-
ated with about a two-fold and five-fold increase in the
odds of developing PIH and PE respectively. This was
however significant for PIH but not PE. This observa-
tion is similar to that observed in other studies [8,9,35]
but contrary to reports of existing significant risk of PE
in a much younger age group (≤21 years) [36]. Acknow-
ledging that PIH and PE may only be different manifes-
tations of the same disease, there is some evidence that
these conditions may be distinct in pathophysiology
[37]. Furthermore, the increased risk of hypertensive
disorders in pregnancy with increasing age has been
Table 5 Multivariate logistic regression model for risk factors associated with PIH and PE
Variable PIH PE
OR (95% CI) p-value OR (95% CI) p-value
Age group
< 25* 1 1
25-29 0.82 (0.22-2.98) 0.757 0.53 (0.13-2.27) 0.395
30-34 0.44 (0.09-2.09) 0.305 0.27 (0.04-1.73) 0.165
35-39 4.00 (0.59-27.25) 0.157 4.8 (0.68-33.80) 0.115
≥ 40 2.14 (0.35-13.27) 0.000 5.14 (0.47-14.87) 0.278
Gravidity
Primigravida* 1 1
Secundigravida 1.91 (0.63-5.73) 0.252 0.48 (0.11-2.08) 0.324
Multigravida 0.52 (0.14-1.97) 0.335 1.04 (0.33-3.24) 0.948
Parity
Nulliparous* 1 1
Primiparous 1.17 (0.39-3.50) 0.786 0.59 (0.16-2.22) 0.433
Multiparous 0.65 (0.17-2.51) 0.529 1.10 (0.32-3.82) 0.881
BMI
Normal* 1 1
Overweight 0.62 (0.19-2.02) 0.427 1.49 (0.43-5.12) 0.527
Obese 0.93 (0.29-3.01) 0.905 0.85 (0.21-3.39) 0.813
Contraceptive use
No* 1 1
Yes 0.49 (0.18-1.37) 0.174 0.64 (0.22-1.82) 0.399
Abortion
No* 1 1
Yes 0.33 (0.08-1.34) 0.122 0.41 (0.10-1.66) 0.212
New paternity
No* 1 1
Yes 0.60 (0.18-1.99) 0.403 1.69 (0.57-5.00) 0.345
Malaria
No* 1 1
Yes 2.92 (0.50-17.15) 0.235 0.00 -
BMI = Body Mass Index, PIH: Pregnancy-induced hypertension; PE: Pre-eclampsia. *Reference. Data in boldface indicate statistical significance.
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occur with ageing [9]. These biological changes may inter-
act differently with the pathophysiological processes of
PIH and PE, hence yielding different outcomes. In a sys-
tematic review of controlled trials [8], women aged ≥40
had about two times the risk of developing pre-eclampsia,
whether they were primiparous or multiparous [38]. This
review however found that most studies failed to address
differences between participants at baseline; hence, only
one study was taken into account. Much therefore re-
mains to be determined concerning age and hypertensive
disorders in pregnancy, especially PE. That notwithstand-
ing, caution must be exercised in assessing risk of PE in
advanced maternal age.How much decline in levels of serum Mg2+ and Ca2+
is associated with an increased risk of hypertension in
pregnancy? At what stage do these changes begin to
manifest as a rise in blood pressure and proteinuria?
Can these electrolytes exhibit a predictive ability for
PIH and PE? To clarify these, it is important to conduct
further studies.
Conclusion
In this study population, levels of serum calcium and
magnesium are significantly low in women with PIH and
PE than in normal pregnancy. Increased maternal age
was associated with an increased risk of PIH but not PE.
This may suggest a cause and effect relationship between
Ephraim et al. BMC Pregnancy and Childbirth 2014, 14:390 Page 7 of 8
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helps to understand the pathophysiological process of
hypertension in pregnancy, and to establish and enhance
existing preventive strategies for the condition. Mineral
supplementation during the antenatal period may influ-
ence significantly, the occurrence of hypertensive disor-
ders in pregnancy.
Limitations
Due to limited resources, we were unable to use more
sensitive and reliable quantitative methods of detecting
proteinuria. Dietary patterns was not determined, thus
the impact of inadequate intake of these minerals as well
as the possible confounding effect of diet remains. There
is limitation on the generalization of the study findings
due to consecutive sampling technique used. Findings
from the study however remain relevant and add to evi-
dence on the subject matter.
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